Tetracycline-responsive gene expression in mouse brain after amplicon-mediated gene transfer

Gene Therapy

Volumn 4, Issue 9, 1997, Pages 901-908

  Fotaki, M E ^a   Pink, J R ^a   Mous, J ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Amplicon vector; Herpes simplex virus; Hippocampus; Regulatable promoter; Tetracycline

Indexed keywords

BETA GALACTOSIDASE; TETRACYCLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CLONING VECTOR; CYTOTOXICITY; DENTATE GYRUS; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE TRANSFER; GRANULAR CELL; HELPER VIRUS; HIPPOCAMPUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENE; VIRION; VIRUS REPLICATION;

EID: 0030867223     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300487     Document Type: Article

References (43)

1. Ward PL, Roizman B. Herpes simplex genes: the blueprint of a successful human pathogen. Trends Genet 1994; 10: 267-274.
2. Dobson AT et al. A latent, nonpathogenic HSV-1-derived vector stably expresses β-galactosidase in mouse neurons. Neuron 1990; 5: 353-360.
3. Fink DJ et al. In vivo expression of β-galactosidase in hippocampal neurons by HSV-mediated gene transfer Hum Gene Ther 1992, 3: 11-19.
4. Breakefield XO et al. Gene transfer into the nervous system using recombinant Herpes virus vectors. In: Gage FH, Christen Y (eds). Gene Transfer and Therapy in the Nervous System. Springer Verlag: Berlin, 1992, pp 118-132.
5. Glorioso JC, Sternberg LR, Goins WF, Fink DJ Development of Herpes simplex virus as a gene transfer vector for central nervous system. In: Gage FH, Christen Y (eds). Gene Transfer and Therapy in the Nervous System. Springer Verlag: Berlin, 1992, pp 133-145.
6. Spaete RR, Frenkel N. The Herpes simplex virus amplicon: a new eucaryotic defective-virus cloning-amplifying vector. Cell 1982; 30: 295-304.
7. Geller AI, Breakefield XO. A defective HSV-1 vector expresses Escherichia coli β-galactosidase in cultured peripheral neurons. Science 1988; 241: 1667-1669.
8. Ali M, Lemoine NR, Ring CJA. The use of DNA viruses as vectors for gene therapy. Gene Therapy 1994; 1: 367-384.
9. Ho DY, Mocarski ES, Sapolsky RM. Altering central nervous system physiology with a defective Herpes simplex virus vector expressing the glucose transporter gene. Proc Natl Acad Sci USA 1993; 90: 3655-3659.
10. During MJ, Naegele JR, O'Malley KL, Geller AI. Long-term behavioral recovery in Parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 1994; 266: 1399-1403.
11. Kaplitt MG, Kwong AD, Kleopoulos SP, Mobbs CV. Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective Herpes simplex viral vector. Proc Natl Acad Sci USA 1994; 91: 8979-8983.
12. Smith RL, Geller AI, Escudero KW, Wilcox CL. Long-term expression in sensory neurons in tissue culture from Herpes simplex virus type-1-derived vector. J Virol 1995; 69: 4593-4599.
13. Wood MJA et al. Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors. Gene Therapy 1994; 1: 283-291.
14. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547-5551.
15. Gossen M et al. Transcriptional activation by tetracyclines in mammalian cells. Science 1995; 268: 1766-1769.
16. Paulus W et al. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J Virol 1996; 70: 62-67.
17. Hofmann A, Nolan GP, Blau HM. Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc Natl Acad Sci USA 1996; 93: 5185-5190.
18. Iida A, Chen S, Friedmann T, Yee J. Inducible gene expression by retrovirus-rnediated transfer of a modified tetracycline-regulated system. J Virol 1996; 70: 6054-6059.
19. Hwang J, Scuric Z, Anderson WF. Novel retroviral vector transferring a suicide gene and a selectable marker gene with enhanced gene expression by using a tetracycline-responsive system. J Virol 1996; 70: 8138-8141.
20. Furth PA et al. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 1994; 91: 9302-9306.
21. Shockett P, Difilippantonio M, Hellman N, Schatz DG. A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc Natl Acad Sci USA 1995; 92: 6522-6526.
22. Kistner A et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 1996; 93: 10933-10938.
23. Schultze N et al. Efficient control of gene expression by single step integration of the tetracycline system in transgenic mice. Nat Biotechnol 1996; 14: 499-503.
24. Sande MA, Mandel GL. Tetracycline, chloramphenicol, erythromycin and miscellaneous antibiotic agents. In: Gilman AG et al (eds). The Pharmacological Basis of Therapeutics. Pergamon: New York, 1990, pp 1117-1125.
25. Corti O et al. Intracerebral tetracycline-dependent regulation of gene expression in grafts of neural precursors. Neuroreport 1996; 7: 1655-1659.
26. Ho DY, McLaughlin JR, Sapolsky RM. Inducible gene expression from defective Herpes simplex virus vectors using the tetracycline-responsive promoter system. Mol Brain Res 1996; 41: 200-209.
27. McGeoch DJ, Dolan A, Donald S, Brauer DHK. Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1. Nucleic Acids Res 1986; 14: 1727-1745.
28. Preston CM, Cordingley MG, Stow ND. Analysis of DNA sequences which regulate the transcription of a Herpes simplex virus immediate-early gene. J Virol 1984; 50: 708-716.
29. Varmuza SL, Smiley JR. Signals for site-specific cleavage of HSV DNA: maturation involves two separate cleavage events at sites distal to the recognition sequences. Cell 1985; 41: 793-802.
30. Martin DW, Weber PC. The a sequence is dispensable for isomerization of the Herpes simplex virus type 1 genome. J Virol 1996; 70: 8801-8812.
31. MacGregor GR et al. Use of E. coli lacZ (β-galactosidase) as a reporter gene. In Murray EJ (ed). Methods in Molecular Biology, vol 7. Humana Press: Clifton, NJ, 1991, pp 217-235.
32. DeLuca NA, McCarthy AM, Schaffer PA. Isolation and characterization of deletion mutants of Herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol 1985; 56: 558-570.
33. McCarthy AM, McMahan L, Schaffer PA. Herpes simplex virus type1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. J Virol 1989; 63: 18-27.
34. DeLuca NA, Schaffer PA. Activities of Herpes simplex type 1 (HSV-1) IC4 genes specifying nonsense peptides. Nucleic Acids Res 1987; 15: 4491-4511.
35. Smith IL, Hardwicke MA, Sandri-Goldin RM. Evidence that the Herpes simplex immediate-early protein ICP27 acts post-transcriptionally during infection to regulate gene expression. Virology 1992; 186: 74-86.
36. Pechan PA et al. A novel 'piggyback' packaging system for Herpes simplex virus amplicon vectors. Hum Gene Ther 1996; 7: 2003-2013.
37. Smibert CA et al. Herpes simplex virus VP16 forms a complex with the virion host shutoff protein vhs. J Virol 1994; 68: 2339-2346.
38. Schmelter J, Knez J, Smiley JR, Capone JP. Identification and characterization of a small modular domain in the Herpes simplex virus host shutoff protein sufficient for interaction with VP16. J Virol 1996; 70: 2124-2131.
39. Lim F et al. Generation of high-titer defective HSV-1 vectors using an IE2 deletion mutant and quantitative study of expression in cultured cortical cells. BioTechniques 1996; 20: 460-469.
40. Zhu Z, DeLuca NA, Schaffer PA. Overexpression of the Herpes simplex virus type 1 immediate-early regulatory protein, ICP27, is responsible for the aberrant localization of ICP0 and mutant forms of ICP4 in ICP4 mutant virus-infected cells. J Virol 1996; 70: 5346-5356.
41. Johnson PA et al. Cytotoxicity of a replication-defective mutant of Herpes simplex virus type 1. J Virol 1992; 66: 2952-2965.
42. Johnson PA, Wang MJ, Friedmann T. Improved cell survival by the reduction of immediate-early gene expression in replication-defective mutants of Herpes simplex virus type 1 but not by mutation of the virion host shutoff function. J Virol 1994; 68: 6347-6362.
43. Starr PA et al. Long-term persistence of defective HSV-1 vectors in the rat brain is demonstrated by reactivation of vector gene expression. Gene Therapy 1996; 3: 615-623.